Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis


Main idea: Preliminary data suggest that fecal microbiota transplantation is a potentially safe, well-tolerated, and efficacious treatment for certain conditions other than Clostridium difficile Infection, with evidence for active ulcerative colitis being the most compelling.


The intestinal microbiome has been identified as a key modifier for a variety of health conditions. Fecal Microbiota Transplantation has emerged as a fast, safe, and effective means by which to modify the intestinal microbiome and potentially treat a variety of health conditions. Serious adverse events were more often reported in control group participants compared with fecal microbiota transplantation group participants. Hepatic disorders, metabolic syndrome, and antibiotic-resistant organisms were conditions with emerging data on fecal bacteria transplantation. There were similar rates of mild to moderate comorbidities in both groups.


Please enter your comment!
Please enter your name here